We are monitoring the impact of COVID-19 on Europe Leukemia Therapeutics Market Get in touch with us for detailed analysis Know More
Share on

Europe Leukemia Therapeutics Market Research Report - Segmented By Disease Condition, Diagnosis, Treatments, Drugs & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends & Forecasts (2022 to 2027)

Published: January, 2022
ID: 766
Pages: 145

Europe Leukemia Therapeutics Market Size & Growth (2022 to 2027)

Europe Leukemia Therapeutics market has been estimated at USD 1.96 Billion in 2022 and is projected to reach USD 2.94 Billion by 2027, at a CAGR of 8.4% during the forecast period from 2022 to 2027.  

Leukemia is commonly caused due to the high exposure to radiation, an unhealthy lifestyle, genetic factors, and environmental conditions. Leukemia cases are more common in adults and are observed to progress with aging. It can be identified by the spread of the diseases and by the type of the blood cell that is affected.

The market for Leukemia Therapeutics in Europe is propelling mainly due to factors like increased innovation and R&D in the oncology sectors and a growing number of biotechnology firms.

But due to factors like the high cost of drugs and treatments along with a large number of entry-to-market barriers, the market growth is feared to diminish.

This research report on the Europe Leukemia Therapeutics Market has been segmented and sub-segmented into the following categories

By Disease Condition:              

  • Chronic Lymphatic Leukemia           
  • Acute Lymphatic Leukemia              
  • Chronic Myeloid Leukemia               
  • Acute Myeloid Leukemia  

By Diagnosis:

  • CT scan     
  • Biopsy       
  • MRI            

By Treatments:

  • Chemotherapy      
  • Radiation therapy
  • Immunotherapy   
  • Surgery     
  • Targeted Therapy
  • Bone marrow transplant   
  • Stem Cell Therapy

By Drugs:

  • Gleevec    
  • Sapacitabine           
  • GA101       
  • Vasaroxine              
  • Tosedosat      

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

By disease condition, chronic myeloid leukemia dominated the overall therapeutic market owing to the high prevalence rate. Stem cell therapy and bone marrow transplant are the emerging trends in the leukemia therapeutics market. Gleevec was one of the major market growth contributors, in the drugs category.

Europe holds the second-largest share in the global market. A number of factors such as growing awareness of leukemia screening programs and government support are paving the way for companies to penetrate into the European Leukemia Therapeutics market.

Key players operating in the Europe Leukemia Therapeutics market profiled in this report are Hoffmann-La Roche Ltd, GlaxoSmithKline Pharmaceuticals Limited, Novartis International AG, Bristol-Myers Squibb, Eisai Co. Ltd, Biogen Idec, ERYtech Pharma, Celgene Corporation, Genmab A/S, Cephalon Inc., Clavis Pharma, and Pfizer Inc.

1. Introduction                             

              1.1 Market Definition                  

              1.2 Study Deliverables                

              1.3 Base Currency, Base Year and Forecast Periods   

              1.4 General Study Assumptions              

2. Research Methodology                                       

              2.1 Introduction                           

              2.2 Research Phases                    

                             2.2.1 Secondary Research          

                             2.2.2 Primary Research

                             2.2.3 Econometric Modelling     

                             2.2.4 Expert Validation 

              2.3 Analysis Design                      

              2.4 Study Timeline                       

3. Overview                                   

              3.1 Executive Summary              

              3.2 Key Inferences                       

              3.3 New Developments              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                

              4.1 Market Drivers                       

              4.2 Market Restraints                  

              4.3 Key Challenges                       

              4.4 Current Opportunities in the Market                           

5. Market Segmentation                                          

              5.1 By Disease Condition                          

                             5.1.1 Chronic Lymphatic Leukemia         

                             5.1.2 Acute Lymphatic Leukemia             

                             5.1.3 Chronic Myeloid Leukemia             

                             5.1.4 Acute Myeloid Leukemia  

              5.2 By Diagnosis                           

                             5.2.1 CT scan    

                             5.2.2 Biopsy      

                             5.2.3 MRI          

              5.3 By Treatments                        

                             5.3.1 Chemotherapy     

                             5.3.2 Radiation therapy

                             5.3.3 Immunotherapy  

                             5.3.4 Surgery    

                             5.3.5 Targeted Therapy

                             5.3.6 Bone marrow transplant  

                             5.3.7 Stem Cell Therapy

              5.4 By Drugs                    

                             5.4.1 Gleevec    

                             5.4.2 Sapacitabine         

                             5.4.3 GA101      

                             5.4.4 Vasaroxine            

                             5.4.5 Tosedosat             

6. Geographical Analysis                                         

                             6.1 Introduction             

                             6.2 U.K 

                             6.3 Spain           

                             6.4 Germany    

                             6.5 Italy             

                             6.6 France         

7. Pipeline Product Analysis                                    

              7.1 Overview                                

              7.2 Pipeline Development Landscape                                 

              7.3 Molecular Targets in the Pipeline                                  

              7.4 Clinical Trials                          

                             7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target    

                             7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target             

                             7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.   

8. Strategic Analysis                                   

              8.1 PESTLE analysis                      

                             8.1.1 Political    

                             8.1.2 Economic

                             8.1.3 Social       

                             8.1.4 Technological       

                             8.1.5 Legal         

                             8.1.6 Environmental     

              8.2 Porter’s Five analysis                          

                             8.2.1 Bargaining Power of Suppliers       

                             8.2.2 Bargaining Power of Consumers   

                             8.2.3 Threat of New Entrants    

                             8.2.4 Threat of Substitute Products and Services             

                             8.2.5 Competitive Rivalry within the Industry     

9. Market Leaders' Analysis                                    

              9.1 F. Hoffmann-La Roche Ltd                 

                             9.1.1 Overview 

                             9.1.2 Product Analysis  

                             9.1.3 Strategic Evaluation and Operations          

                             9.1.4 Financial analysis 

                             9.1.5 Legal issues           

                             9.1.6 Recent Developments       

                             9.1.7 SWOT analysis      

                             9.1.8 Analyst View         

              9.2 GlaxoSmithKline Pharmaceuticals Limited                  

              9.3 Novartis International AG                  

              9.4 Bristol-Myers Squibb                          

              9.5 Eisai Co. Ltd              

              9.6 Biogen Idec               

              9.7 ERYtech Pharma                    

              9.8 Celgene Corporation                           

              9.9 Genmab A/S                           

              9.10 Cephalon Inc.                       

              9.11 Clavis Pharma                      

              9.12 Pfizer Inc.                

10. Competitive Landscape                                     

              10.1 Market share analysis                      

              10.2 Merger and Acquisition Analysis                  

              10.3 Agreements, collaborations and Joint Ventures                    

              10.4 New Product Launches                     

11. Expert Opinions                                   

              11.1 Market Outlook                   

              11.2 Investment Opportunities               

Appendix                                       

              a) List of Tables              

              b) List of Figures                           

  1. Europe Leukemia Therapeutics Market By Region, From 2022 - 2027 (USD Billion)
  2. Europe Leukemia Therapeutics Market By Disease condition, From 2022 - 2027 (USD Billion)
  3. Europe Cchronic Lymphatic Leukemia Market By Region, From 2022 - 2027 (USD Billion)
  4. Europe Acute Lymphatic Leukemia Market By Region, From 2022 - 2027 (USD Billion)
  5. Europe Chronic Myeloid Leukemia Market By Region, From 2022 - 2027 (USD Billion)
  6. Europe Acute Myeloid Leukemia Market By Region, From 2022 - 2027 (USD Billion)
  7. Europe Leukemia Therapeutics Market By Diagnosis, From 2022 - 2027 (USD Billion)
  8. Europe Leukemia CT scan Market By Region, From 2022 - 2027 (USD Billion)
  9. Europe Leukemia Biopsy Market By Region, From 2022 - 2027 (USD Billion)
  10. Europe Leukemia MRI Market By Region, From 2022 - 2027 (USD Billion)
  11. Europe Leukemia Therapeutics Market By Treatments, From 2022 - 2027 (USD Billion)
  12. Europe Leukemia Chemotherapy Market By Region, From 2022 - 2027 (USD Billion)
  13. Europe Leukemia Radiation Therapy Market By Region, From 2022 - 2027 (USD Billion)
  14. Europe Leukemia Immunotherapy Market By Region, From 2022 - 2027 (USD Billion)
  15. Europe Leukemia Surgery Market By Region, From 2022 - 2027 (USD Billion)
  16. Europe Leukemia Targeted Therapy Market By Region, From 2022 - 2027 (USD Billion)
  17. Europe Leukemia Bone marrow transplant Market By Region, From 2022 - 2027 (USD Billion)
  18. Europe Leukemia Stem Cell Therapy Market By Region, From 2022 - 2027 (USD Billion)
  19. Europe Leukemia Therapeutics Market By Drugs, From 2022 - 2027 (USD Billion)
  20. Europe Leukemia Gleevec Market By Region, From 2022 - 2027 (USD Billion)
  21. Europe Leukemia Sepecitabine Market By Region, From 2022 - 2027 (USD Billion)
  22. Europe Leukemia GA101 Market By Region, From 2022 - 2027 (USD Billion)
  23. Europe Leukemia Vasaroxine Market By Region, From 2022 - 2027 (USD Billion)
  24. Europe Leukemia Tosedosat Market By Region, From 2022 - 2027 (USD Billion)
  25. U.K Leukemia Therapeutics Market By Disease condition, From 2022 - 2027 (USD Billion)
  26. U.K Leukemia Therapeutics Market By Diagnosis, From 2022 - 2027 (USD Billion)
  27. U.K Leukemia Therapeutics Market By Treatments, From 2022 - 2027 (USD Billion)
  28. U.K Leukemia Therapeutics Market By Drugs, From 2022 - 2027 (USD Billion)
  29. Spain Leukemia Therapeutics Market By Disease condition, From 2022 - 2027 (USD Billion)
  30. Spain Leukemia Therapeutics Market By Diagnosis, From 2022 - 2027 (USD Billion)
  31. Spain Leukemia Therapeutics Market By Treatments, From 2022 - 2027 (USD Billion)
  32. Spain Leukemia Therapeutics Market By Drugs, From 2022 - 2027 (USD Billion)
  33. Germany Leukemia Therapeutics Market By Disease condition, From 2022 - 2027 (USD Billion)
  34. Germany Leukemia Therapeutics Market By Diagnosis, From 2022 - 2027 (USD Billion)
  35. Germany Leukemia Therapeutics Market By Treatments, From 2022 - 2027 (USD Billion)
  36. Germany Leukemia Therapeutics Market By Drugs, From 2022 - 2027 (USD Billion)
  37. Italy Leukemia Therapeutics Market By Disease condition, From 2022 - 2027 (USD Billion)
  38. Italy Leukemia Therapeutics Market By Diagnosis, From 2022 - 2027 (USD Billion)
  39. Italy Leukemia Therapeutics Market By Treatments, From 2022 - 2027 (USD Billion)
  40. Italy Leukemia Therapeutics Market By Drugs, From 2022 - 2027 (USD Billion)
  41. France Leukemia Therapeutics Market By Disease condition, From 2022 - 2027 (USD Billion)
  42. France Leukemia Therapeutics Market By Diagnosis, From 2022 - 2027 (USD Billion)
  43. France Leukemia Therapeutics Market By Treatments, From 2022 - 2027 (USD Billion)
  44. France Leukemia Therapeutics Market By Drugs, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample